Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Shin, DM; Donato, NJ; Perez-Soler, R; Shin, HJC; Wu, JY; Zhang, P; Lawhorn, K; Khuri, FR; Glisson, BS; Myers, J; Clayman, G; Pfister, D; Falcey, J; Waksal, H; Mendelsohn, J; Hong, WK
   Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer
   CLINICAL CANCER RESEARCH
   
   D.M. Shin et al., "Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer", CLIN CANC R, 7(5), 2001, pp. 1204-1213
2. Glisson, BS
   Head and neck cancer
   CURRENT OPINION IN ONCOLOGY
   
   B.S. Glisson, "Head and neck cancer", CURR OPIN O, 13(3), 2001, pp. 167-167
3. Pisters, KMW; Newman, RA; Coldman, B; Shin, DM; Khuri, FR; Hong, WK; Glisson, BS; Lee, JS
   Phase I trial of oral green tea extract in adult patients with solid tumors
   JOURNAL OF CLINICAL ONCOLOGY
   
   K.M.W. Pisters et al., "Phase I trial of oral green tea extract in adult patients with solid tumors", J CL ONCOL, 19(6), 2001, pp. 1830-1838
4. Shin, DM; Khuri, FR; Murphy, B; Garden, AS; Clayman, G; Francisco, M; Liu, D; Glisson, BS; Ginsberg, L; Papadimitrakopoulou, V; Myers, J; Morrison, W; Gillenwater, A; Ang, KK; Lippman, SM; Goepfert, H; Hong, WK
   Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: Novel bioadjuvant phase II trial
   JOURNAL OF CLINICAL ONCOLOGY
   
   D.M. Shin et al., "Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: Novel bioadjuvant phase II trial", J CL ONCOL, 19(12), 2001, pp. 3010-3017
5. Tseng, JE; Glisson, BS; Khuri, FR; Shin, DM; Myers, JN; El-Naggar, AK; Roach, JS; Ginsberg, LE; Thall, PF; Wang, XM; Teddy, S; Lawhorn, KN; Zentgraf, RE; Steinhaus, GD; Pluda, JM; Abbruzzese, JL; Hong, WK; Herbst, RS
   Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck
   CANCER
   
   J.E. Tseng et al., "Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck", CANCER, 92(9), 2001, pp. 2364-2373
6. Shin, DM; Khuri, FR; Glisson, BS; Ginsberg, L; Papadimitrakopoulou, VM; Clayman, G; Lee, JJ; Ang, KK; Lippman, SM; Hong, WK
   Phase II study of paclitaxel, ifosfamide, and carboplatin in patients withrecurrent or metastatic head and neck squamous cell carcinoma
   CANCER
   
   D.M. Shin et al., "Phase II study of paclitaxel, ifosfamide, and carboplatin in patients withrecurrent or metastatic head and neck squamous cell carcinoma", CANCER, 91(7), 2001, pp. 1316-1323
7. Glisson, BS
   Head and neck cancer
   CURRENT OPINION IN ONCOLOGY
   
   B.S. Glisson, "Head and neck cancer", CURR OPIN O, 12(3), 2000, pp. 205-206
8. Yen, N; Ioannides, CG; Xu, K; Swisher, SG; Lawrence, DD; Kemp, BL; El-Naggar, AK; Cristiano, RJ; Fang, BL; Glisson, BS; Hong, WK; Khuri, FR; Kurie, JM; Lee, JJ; Lee, JS; Merritt, JA; Mukhopadhyay, T; Nesbitt, JC; Nguyen, D; Perez-Soler, R; Pisters, KMW; Putnam, JB; Schrump, DS; Shin, DM; Walsh, GL; Roth, JA
   Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53)
   CANCER GENE THERAPY
   
   N. Yen et al., "Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53)", CANC GENE T, 7(4), 2000, pp. 530-536
9. Nemunaitis, J; Swisher, SG; Timmons, T; Connors, D; Mack, M; Doerksen, L; Weill, D; Wait, J; Lawrence, DD; Kemp, BL; Fossella, F; Glisson, BS; Hong, WK; Khuri, FR; Kurie, JM; Lee, JJ; Lee, JS; Nguyen, DM; Nesbitt, JC; Perez-Soler, R; Pisters, KMW; Putnam, JB; Richli, WR; Shin, DM; Walsh, GL; Merritt, J; Roth, J
   Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumorsof patients with non-small-cell lung cancer
   JOURNAL OF CLINICAL ONCOLOGY
   
   J. Nemunaitis et al., "Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumorsof patients with non-small-cell lung cancer", J CL ONCOL, 18(3), 2000, pp. 609-622
10. Oh, Y; Perez-Soler, R; Fossella, FV; Glisson, BS; Kurie, J; Walsh, GL; Truong, M; Shin, DM
    Phase II study of intravenous Doxil (R) in malignant pleural mesothelioma
    INVESTIGATIONAL NEW DRUGS
    
    Y. Oh et al., "Phase II study of intravenous Doxil (R) in malignant pleural mesothelioma", INV NEW DR, 18(3), 2000, pp. 243-245
11. Khuri, FR; Shin, DM; Glisson, BS; Lippman, SM; Hong, WK
    Treatment of patients with recurrent or metastatic squamous cell carcinomaof the head and neck: Current status and future directions
    SEMINARS IN ONCOLOGY
    
    F.R. Khuri et al., "Treatment of patients with recurrent or metastatic squamous cell carcinomaof the head and neck: Current status and future directions", SEMIN ONCOL, 27(4), 2000, pp. 25-33
12. Glisson, BS; Kurie, JM; Perez-Soler, R; Fox, NJ; Murphy, WK; Fossella, FV; Lee, JS; Ross, MB; Nyberg, DA; Pisters, KMW; Shin, DM; Hong, WK
    Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma
    JOURNAL OF CLINICAL ONCOLOGY
    
    B.S. Glisson et al., "Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma", J CL ONCOL, 17(8), 1999, pp. 2309-2315
13. Garden, AS; Glisson, BS; Ang, KK; Morrison, WH; Lippman, SM; Byers, RM; Geara, F; Clayman, GL; Shin, DM; Callender, DL; Khuri, FR; Goepfert, H; Hong, WK; Peters, LJ
    Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: Toxicities and responses
    JOURNAL OF CLINICAL ONCOLOGY
    
    A.S. Garden et al., "Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: Toxicities and responses", J CL ONCOL, 17(8), 1999, pp. 2390-2395
14. Swisher, SG; Roth, JA; Nemunaitis, J; Lawrence, DD; Kemp, BL; Carrasco, CH; Connors, DG; El-Naggar, AK; Fossella, F; Glisson, BS; Hong, WK; Khuri, FR; Kurie, JM; Lee, JJ; Lee, JS; Mack, M; Merritt, JA; Nguyen, DM; Nesbitt, JC; Perez-Soler, R; Pisters, KMW; Putnam, JB; Richli, WR; Savin, M; Schrump, DS; Shin, DM; Shulkin, A; Walsh, GL; Wait, J; Weill, D; Waugh, MKA
    Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    S.G. Swisher et al., "Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer", J NAT CANC, 91(9), 1999, pp. 763-771
15. KHURI FR; FOSSELLA FV; LEE JS; MURPHY WK; SHIN DM; MARKOWITZ AB; GLISSON BS
    PHASE-II TRIAL OF RECOMBINANT IFN-ALPHA-2A WITH ETOPOSIDE CISPLATIN INDUCTION AND INTERFERON/MEGESTROL ACETATE MAINTENANCE IN EXTENSIVE SMALL-CELL LUNG-CANCER/
    Journal of interferon & cytokine research
    
    F.R. Khuri et al., "PHASE-II TRIAL OF RECOMBINANT IFN-ALPHA-2A WITH ETOPOSIDE CISPLATIN INDUCTION AND INTERFERON/MEGESTROL ACETATE MAINTENANCE IN EXTENSIVE SMALL-CELL LUNG-CANCER/", Journal of interferon & cytokine research, 18(4), 1998, pp. 241-245
16. LEE JS; PISTERS KMW; KOMAKI R; GLISSON BS; PEREZSOLER R; KHURI FR; DELCLOS ME; FOSSELLA FV
    THE ROLE OF PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS A PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER/
    Annals of oncology
    
    J.S. Lee et al., "THE ROLE OF PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS A PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER/", Annals of oncology, 9, 1998, pp. 660-660
17. SHIN DM; GLISSON BS; KHURI FR; GINSBERG L; PAPADIMITRAKOPOULOU V; LEE JJ; LAWHORN K; GILLENWATER AM; ANG KK; CLAYMAN GL; CALLENDER DL; HONG WK; LIPPMAN SM
    PHASE-II TRIAL OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA
    Journal of clinical oncology
    
    D.M. Shin et al., "PHASE-II TRIAL OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA", Journal of clinical oncology, 16(4), 1998, pp. 1325-1330
18. LEE JS; KOMAKI R; FOSSELLA FV; GLISSON BS; HONG WK; COX JD
    A PILOT TRIAL OF HYPERFRACTIONATED THORACIC RADIATION-THERAPY WITH CONCURRENT CISPLATIN AND ORAL ETOPOSIDE FOR LOCALLY ADVANCED INOPERABLE NON-SMALL-CELL LUNG-CANCER - A 5-YEAR FOLLOW-UP REPORT
    International journal of radiation oncology, biology, physics
    
    J.S. Lee et al., "A PILOT TRIAL OF HYPERFRACTIONATED THORACIC RADIATION-THERAPY WITH CONCURRENT CISPLATIN AND ORAL ETOPOSIDE FOR LOCALLY ADVANCED INOPERABLE NON-SMALL-CELL LUNG-CANCER - A 5-YEAR FOLLOW-UP REPORT", International journal of radiation oncology, biology, physics, 42(3), 1998, pp. 479-486
19. ROTH JA; SWISHER SG; MERRITT JA; LAWRENCE DD; KEMP BL; CARRASCO CH; ELNAGGAR AK; FOSSELLA FV; GLISSON BS; HONG WK; KHURL FR; KURIE JM; NESBITT JC; PISTERS K; PUTNAM JB; SCHRUMP DS; SHIN DM; WALSH GL
    GENE-THERAPY FOR NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT OF A PHASE-I TRIAL OF ADENOVIRAL P53 GENE REPLACEMENT
    Seminars in oncology
    
    J.A. Roth et al., "GENE-THERAPY FOR NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT OF A PHASE-I TRIAL OF ADENOVIRAL P53 GENE REPLACEMENT", Seminars in oncology, 25(3), 1998, pp. 33-37
20. SHIN DM; GLISSON BS; KHURI FR; HONG WK; LIPPMAN SM
    ROLE OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    Seminars in oncology
    
    D.M. Shin et al., "ROLE OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK", Seminars in oncology, 25(2), 1998, pp. 40-44
21. ROTH JA; SWISHER SG; LAWRENCE DD; KEMP BL; CARRASCO CH; ELNAGGAR AK; FOSSELA FV; GLISSON BS; HONG WK; KHURI FR; KURIE JM; NESBITT JC; PISTERS K; PUTNAM JB; SCHRUMP DS; SHIN DM; WALSH GL
    LOCAL AND SYSTEMIC STRATEGIES FOR GENE REPLACEMENT FOR CANCER
    British Journal of Cancer
    
    J.A. Roth et al., "LOCAL AND SYSTEMIC STRATEGIES FOR GENE REPLACEMENT FOR CANCER", British Journal of Cancer, 78(2), 1998, pp. 142-142
22. SHIN DM; GLISSON BS; KHURI FR; GINSBERG L; LAWHORN K; HONG WK; LIPPMAN SM
    RECENT ADVANCES IN PACILITAXEL-CONTAINING CHEMOTHERAPY FOR RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    Seminars in oncology
    
    D.M. Shin et al., "RECENT ADVANCES IN PACILITAXEL-CONTAINING CHEMOTHERAPY FOR RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK", Seminars in oncology, 24(6), 1997, pp. 33-37
23. LEE JS; PISTERS KMW; KOMAKI R; GLISSON BS; KHURI FR; SCHEA R; FOSSELLA FV
    PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT/
    Seminars in oncology
    
    J.S. Lee et al., "PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT/", Seminars in oncology, 24(4), 1997, pp. 52-55
24. GEARA FB; GLISSON BS; SANGUINETI G; TUCKER SL; GARDEN AS; ANG KK; LIPPMAN SM; CLAYMAN GL; GOEPFERT H; PETERS LJ; HONG WK
    INDUCTION CHEMOTHERAPY FOLLOWED BY RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN PATIENTS WITH ADVANCED NASOPHARYNGEAL CARCINOMA - RESULTS OF AMATCHED COHORT STUDY
    Cancer
    
    F.B. Geara et al., "INDUCTION CHEMOTHERAPY FOLLOWED BY RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN PATIENTS WITH ADVANCED NASOPHARYNGEAL CARCINOMA - RESULTS OF AMATCHED COHORT STUDY", Cancer, 79(7), 1997, pp. 1279-1286
25. GLISSON BS; HONG WK
    SURVIVAL AFTER TREATMENT OF SMALL-CELL LUNG-CANCER - AN ENDLESS UPHILL BATTLE
    Journal of the National Cancer Institute
    
    B.S. Glisson e W.K. Hong, "SURVIVAL AFTER TREATMENT OF SMALL-CELL LUNG-CANCER - AN ENDLESS UPHILL BATTLE", Journal of the National Cancer Institute, 89(23), 1997, pp. 1745-1747
26. PEREZSOLER R; FOSSELLA FV; GLISSON BS; LEE JS; MURPHY WK; SHIN DM; KEMP BL; LEE JJ; KANE J; ROBINSON RA; LIPPMAN SM; KURIE JM; HUBER MH; RABER MN; HONG WK
    PHASE-II STUDY OF TOPOTECAN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER PREVIOUSLY UNTREATED WITH CHEMOTHERAPY
    Journal of clinical oncology
    
    R. Perezsoler et al., "PHASE-II STUDY OF TOPOTECAN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER PREVIOUSLY UNTREATED WITH CHEMOTHERAPY", Journal of clinical oncology, 14(2), 1996, pp. 503-513
27. PEREZSOLER R; GLISSON BS; LEE JS; FOSSELLA FV; MURPHY WK; SHIN DM; HONG WK
    TREATMENT OF PATIENTS WITH SMALL-CELL LUNG CANCER REFRACTORY TO ETOPOSIDE AND CISPLATIN WITH THE TOPOISOMERASE-I POISON TOPOTECAN
    Journal of clinical oncology
    
    R. Perezsoler et al., "TREATMENT OF PATIENTS WITH SMALL-CELL LUNG CANCER REFRACTORY TO ETOPOSIDE AND CISPLATIN WITH THE TOPOISOMERASE-I POISON TOPOTECAN", Journal of clinical oncology, 14(10), 1996, pp. 2785-2790
28. GARDEN AS; LIPPMAN SM; MORRISON WH; GLISSON BS; ANG KK; GEARA F; HONG WK; PETERS LJ
    DOES INDUCTION CHEMOTHERAPY HAVE A ROLE IN THE MANAGEMENT OF NASOPHARYNGEAL CARCINOMA - RESULTS OF TREATMENT IN THE ERA OF COMPUTERIZED-TOMOGRAPHY
    International journal of radiation oncology, biology, physics
    
    A.S. Garden et al., "DOES INDUCTION CHEMOTHERAPY HAVE A ROLE IN THE MANAGEMENT OF NASOPHARYNGEAL CARCINOMA - RESULTS OF TREATMENT IN THE ERA OF COMPUTERIZED-TOMOGRAPHY", International journal of radiation oncology, biology, physics, 36(5), 1996, pp. 1005-1012
29. GLISSON BS; HONG WK
    PRIMARY CHEMOTHERAPY OF ADVANCED HEAD AND NECK-CANCER - WHERE DO WE GO FROM HERE
    Journal of the National Cancer Institute
    
    B.S. Glisson e W.K. Hong, "PRIMARY CHEMOTHERAPY OF ADVANCED HEAD AND NECK-CANCER - WHERE DO WE GO FROM HERE", Journal of the National Cancer Institute, 88(9), 1996, pp. 567-568
30. PEREZSOLER R; FOSSELLA FV; MURPHY WK; GLISSON BS; LEE JS; HONG WK
    PHASE-II STUDY OF TOPOTECAN IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE LUNG PREVIOUSLY UNTREATED WITH CHEMOTHERAPY
    European journal of cancer
    
    R. Perezsoler et al., "PHASE-II STUDY OF TOPOTECAN IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE LUNG PREVIOUSLY UNTREATED WITH CHEMOTHERAPY", European journal of cancer, 31A, 1995, pp. 1076-1076
31. KOMAKI R; SHIN DM; GLISSON BS; FOSSELLA FV; MURPHY WK; GARDEN AS; OSWALD MJ; HONG WK; ROTH JA; PETERS LJ; HOLOYE PV; ELLERBROEK N
    INTERDIGITATING VERSUS CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED SMALL-CELL LUNG-CANCER
    International journal of radiation oncology, biology, physics
    
    R. Komaki et al., "INTERDIGITATING VERSUS CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED SMALL-CELL LUNG-CANCER", International journal of radiation oncology, biology, physics, 31(4), 1995, pp. 807-811
32. FISK B; IOANNIDES CG; AGGARWAL S; WHARTON JT; OBRIAN CA; RESTIFO N; GLISSON BS
    ENHANCED EXPRESSION OF HLA-A,B,C AND INDUCIBILITY OF TAP-1, TAP-2, AND HLA-A,B,C BY INTERFERON-GAMMA IN A MULTIDRUG-RESISTANT SMALL-CELL LUNG-CANCER LINE
    Lymphokine and cytokine research
    
    B. Fisk et al., "ENHANCED EXPRESSION OF HLA-A,B,C AND INDUCIBILITY OF TAP-1, TAP-2, AND HLA-A,B,C BY INTERFERON-GAMMA IN A MULTIDRUG-RESISTANT SMALL-CELL LUNG-CANCER LINE", Lymphokine and cytokine research, 13(2), 1994, pp. 125-131
33. LIPPMAN SM; GLISSON BS; KAVANAGH JJ; LOTAN R; HONG WK; PAREDESESPINOZA M; HITTELMAN WN; HOLDENER EE; KRAKOFF IH
    RETINOIC ACID AND INTERFERON COMBINATION STUDIES IN HUMAN CANCER
    European journal of cancer
    
    S.M. Lippman et al., "RETINOIC ACID AND INTERFERON COMBINATION STUDIES IN HUMAN CANCER", European journal of cancer, 29A, 1993, pp. 9-13